AIM
BHC icon

Advantage Investment Management’s Bausch Health BHC Stock Holding History

Advantage Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-391
Closed -$6K – 1005
2017
Q3 		$6K Hold
391
– – ﹤0.01% 781
2017
Q2 		$7K Hold
391
– – ﹤0.01% 766
2017
Q1 		$4K Sell
391
-225
-37% -$3.1K ﹤0.01% 825
2016
Q4 		$9K Sell
616
-870
-59% -$16K ﹤0.01% 645
2016
Q3 		$36K Sell
1,486
-143
-9% -$3.7K 0.01% 394
2016
Q2 		$33K Buy
1,629
+300
+23% +$8.49K 0.02% 397
2016
Q1 		$35K Buy
+1,329
New +$98.3K 0.02% 379

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advantage Investment Management's BHC Position: Q4 2017 in Review

Advantage Investment Management sold out of Bausch Health (BHC) in Q4 2017, closing a stake of 391 shares — an estimated $6K sold.

Advantage Investment Management first reported a position in BHC in Q1 2016 and held it in 7 quarters. The position peaked at $36K in Q3 2016. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

  • Advantage Investment Management reported no remaining Bausch Health position as of Q4 2017 after selling out during the quarter.
  • Advantage Investment Management sold 391 Bausch Health shares in Q4 2017, an estimated $6K.
  • Advantage Investment Management first reported a position in Bausch Health in Q1 2016 and held it in 7 quarters.
  • Advantage Investment Management's Bausch Health position peaked at $36K in Q3 2016.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on Advantage Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.